The Acromegaly Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. It is composed of drugs used to treat acromegaly, a condition caused by an excess of growth hormone. These drugs are used to reduce the production of growth hormone, reduce its effects, or both. Commonly used drugs include somatostatin analogs, dopamine agonists, and GH receptor antagonists. Surgery is also an option for some patients. The Acromegaly Drug market is highly competitive, with many companies offering treatments. Some of the major players in the market include Novartis, Pfizer, Ipsen, and Teva Pharmaceuticals. Other companies include Sandoz, Merck, and Eli Lilly. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
